Literature DB >> 6761124

Dopamine in the treatment of heart failure.

S I Rajfer, L I Goldberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6761124

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  6 in total

Review 1.  Clinical relevance of long-term therapy with levodopa and orally active dopamine analogues in patients with chronic congestive heart failure.

Authors:  G Hasenfuss; H Just
Journal:  Basic Res Cardiol       Date:  1989       Impact factor: 17.165

Review 2.  Unravelling the role of epigenetics in reproductive adaptations to early-life environment.

Authors:  Ben Bar-Sadeh; Sergei Rudnizky; Lilach Pnueli; Gillian R Bentley; Reinhard Stöger; Ariel Kaplan; Philippa Melamed
Journal:  Nat Rev Endocrinol       Date:  2020-07-03       Impact factor: 43.330

3.  Dopexamine: a novel agonist at peripheral dopamine receptors and beta 2-adrenoceptors.

Authors:  R A Brown; J Dixon; J B Farmer; J C Hall; R G Humphries; F Ince; S E O'Connor; W T Simpson; G W Smith
Journal:  Br J Pharmacol       Date:  1985-07       Impact factor: 8.739

4.  Haemodynamic evaluation of ibopamine in severe congestive heart failure.

Authors:  G C Reffo; M Turrin; A Gabellini; C Forattini
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

5.  The effects of dopexamine on the cardiovascular system of the dog.

Authors:  R A Brown; J B Farmer; J C Hall; R G Humphries; S E O'Connor; G W Smith
Journal:  Br J Pharmacol       Date:  1985-07       Impact factor: 8.739

6.  The inotropic effects of dopamine and its precursor levodopa on isolated human ventricular myocardium.

Authors:  L Brown; B Lorenz; E Erdmann
Journal:  Klin Wochenschr       Date:  1985-11-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.